Co-Authors
This is a "connection" page, showing publications co-authored by Jérôme de Sèze and Nicolas Collongues.
Connection Strength
0.879
-
Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti-SARS-CoV-2 Antibodies: An Observational Study. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
Score: 0.240
-
Impact of disease-modifying treatments on humoral response after COVID-19 vaccination: A mirror of the response after SARS-CoV-2 infection. Rev Neurol (Paris). 2021 Dec; 177(10):1237-1240.
Score: 0.238
-
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders. Eur J Neurol. 2021 Oct; 28(10):3461-3466.
Score: 0.229
-
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021 Sep; 71:103561.
Score: 0.060
-
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurol. 2020 09 01; 77(9):1079-1088.
Score: 0.056
-
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. EBioMedicine. 2020 Sep; 59:102915.
Score: 0.056